Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03609853 · ClinicalTrials.gov registry record · Phase 1
Behavioral Pharmacology of THC and D-limonene
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 53
- Enrollment target
NCT03609853: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT03609853 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03609853, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 53 participants
- Enrollment target
Study Summary
This study will evaluate the pharmacokinetics and pharmacodynamics of vaporized d-limonene and THC administered via inhalation.
Interventions
- DRUG Placebo
- DRUG Vaporized THC, limonene, or THC and limonene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2023-10-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03609853
The ClinicalTrials.gov registry entry for NCT03609853 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03609853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03609853 about?
NCT03609853 is a clinical study titled "Behavioral Pharmacology of THC and D-limonene". This study will evaluate the pharmacokinetics and pharmacodynamics of vaporized d-limonene and THC administered via inhalation.
What is the current status of trial NCT03609853?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 53 participants. The study started on 2019-04-01. Estimated completion is 2023-10-25.
What interventions are being tested in trial NCT03609853?
The interventions under investigation include: Placebo (DRUG), Vaporized THC, limonene, or THC and limonene (DRUG).
Who is sponsoring clinical trial NCT03609853?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.